MLL-AF9 leukemias are sensitive to PARP1 inhibitors combined with cytotoxic drugs

  • Silvia Maifrede
  • , Esteban Martinez
  • , Margaret Nieborowska-Skorska
  • , Daniela Di Marcantonio
  • , Michael Hulse
  • , Bac Viet Le
  • , Huaqing Zhao
  • , Katarzyna Piwocka
  • , Italo Tempera
  • , Stephen M. Sykes
  • , Tomasz Skorski

Research output: Contribution to journalArticlepeer-review

28 Scopus citations
Original languageEnglish
Pages (from-to)1467-1472
Number of pages6
JournalBlood Advances
Volume1
Issue number19
DOIs
StatePublished - Aug 22 2017

Cite this